These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3109487)

  • 1. Characterization of the aflatoxin B1-binding site of rat albumin.
    Dirr HW; Schabort JC
    Biochim Biophys Acta; 1987 Jul; 913(3):300-7. PubMed ID: 3109487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation of the lone tryptophan residue of rat alpha-foetoprotein in its drug-binding sites. Comparison with rat serum albumin.
    Hervé F; Martin MT; Rajkowski K; Dessen P; Cittanova N
    Biochem J; 1987 May; 244(1):81-5. PubMed ID: 2444212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aflatoxin B1 transport in rat blood plasma. Binding to albumin in vivo and in vitro and spectrofluorimetric studies into the nature of the interaction.
    Dirr HW; Schabort JC
    Biochim Biophys Acta; 1986 May; 881(3):383-90. PubMed ID: 3083869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of hydrogen ion and fatty acid concentrations on the binding of aflatoxin B1 to human albumin.
    Dirr HW
    Biochem Int; 1987 Apr; 14(4):727-33. PubMed ID: 3134025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-binding properties of rat alpha 1-foetoprotein. Binding of warfarin, phenylbutazone, azapropazone, diazepam, digitoxin and cholic acid.
    Hervé F; Rajkowski K; Martin MT; Dessen P; Cittanova N
    Biochem J; 1984 Jul; 221(2):401-6. PubMed ID: 6206846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
    Kragh-Hansen U
    Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorometric studies on the binding of aflatoxin B1 to bovine serum albumin.
    Picconi MA; Picó GA; Gatti CA
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):141-7. PubMed ID: 6427862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence studies of the interactions of serum albumin and rat alpha1-fetoprotein with aflatoxin B1. Specificity and binding parameters.
    Evrain C; Cittanova N; Jayle MF
    Biochim Biophys Acta; 1978 Apr; 533(2):408-14. PubMed ID: 77164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of aflatoxin B1, G1 and M to plasma albumin.
    Nassar AY; Megalla SE; El-Fattah HM; Hafez AH; El-Deap TS
    Mycopathologia; 1982 Jul; 79(1):35-8. PubMed ID: 6811900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-binding properties of human alpha-foetoprotein.
    Hirano K; Watanabe Y; Adachi T; Ito Y; Sugiura M
    Biochem J; 1985 Oct; 231(1):189-91. PubMed ID: 2415113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence energy transfer study of the relationship between the lone tryptophan residue and drug binding sites in human serum albumin.
    Kasai S; Horie T; Mizuma T; Awazu S
    J Pharm Sci; 1987 May; 76(5):387-92. PubMed ID: 3656100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1.
    Gan LS; Skipper PL; Peng XC; Groopman JD; Chen JS; Wogan GN; Tannenbaum SR
    Carcinogenesis; 1988 Jul; 9(7):1323-5. PubMed ID: 3133131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-binding properties of rat alpha-foetoprotein. Specificities of the phenylbutazone-binding and warfarin-binding sites.
    Hervé F; Rajkowski KM; Martin MT; Dessen P; Cittanova N
    Biochem J; 1986 Oct; 239(2):451-8. PubMed ID: 2434073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of Non-Covalent Interactions of Aflatoxins (B1, B2, G1, G2, and M1) with Serum Albumin.
    Poór M; Bálint M; Hetényi C; Gődér B; Kunsági-Máté S; Kőszegi T; Lemli B
    Toxins (Basel); 2017 Oct; 9(11):. PubMed ID: 29068381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of site I on human serum albumin: concept about the structure of a drug binding site.
    Yamasaki K; Maruyama T; Kragh-Hansen U; Otagiri M
    Biochim Biophys Acta; 1996 Jul; 1295(2):147-57. PubMed ID: 8695640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinogen-nucleic acid interactions: equilibrium binding studies of aflatoxins B1 and B2 with DNA and the oligodeoxynucleotide d(ATGCAT)2.
    Stone MP; Gopalakrishnan S; Harris TM; Graves DE
    J Biomol Struct Dyn; 1988 Apr; 5(5):1025-41. PubMed ID: 3152158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrophotofluorometric evidence of negatively cooperative binding of warfarin and phenylbutazone to human serum albumin.
    Madsen BW; Tearne PD
    Life Sci; 1980 Jan; 26(3):173-9. PubMed ID: 7360001
    [No Abstract]   [Full Text] [Related]  

  • 18. Aflatoxin B1 binding to plasma albumin and liver DNA upon chronic administration to rats.
    Wild CP; Garner RC; Montesano R; Tursi F
    Carcinogenesis; 1986 Jun; 7(6):853-8. PubMed ID: 3085966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular uptake of aflatoxin B1 by non-ionic diffusion. Inhibition of bile acid transport by interference with membrane lipids.
    Müller N; Petzinger E
    Biochim Biophys Acta; 1988 Mar; 938(3):334-44. PubMed ID: 3126815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vivo disposition of aflatoxin B1 in rat liver.
    Ewaskiewicz JI; Devlin TM; Ch'ih JJ
    Biochem Biophys Res Commun; 1991 Sep; 179(2):1095-100. PubMed ID: 1910338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.